Neuropeptides continue to attract scientific attention for their ability to influence brain signaling, metabolic regulation, and cellular resilience. Within this field, the VGF precursor protein has emerged as a source of short bioactive fragments that act as signaling molecules in experimental systems. Among these, PE 22–28 is a synthetic analog modeled after a VGF-derived peptide, studied for its observed roles in synaptic plasticity, neuronal protection, and metabolic stress adaptation (Alqarni & Alsebai).
This article provides an overview of PE 22–28’s structure, mechanisms of action, and research applications. All findings discussed are derived from experimental research models and should not be interpreted as evidence for therapeutic or clinical use.
